We’ve worked with colleagues at home and abroad to deliver outstanding academic research projects.
Our academic research collaborations range from the development and characterisation of novel compounds, to high throughput screening and quantitative imaging. In addition, we maintain our commitment to leadership in the field of drug discovery research through work with professional associations. Here is a sampling of some of our recent collaborative work in academia:
Novel Compounds and Delivery Systems
Genomic, proteomic and metabolic characterisation of novel organometallic compound [Os(η(6)-p-cymene)(4-(2-pyridylazo)-N,N-dimethylaniline
Professor Peter Sadler, University of Warwick, United Kingdom
Synthesis of 6,8,9 Poly-substituted Purine Analogue Libraries as Pro-Apoptotic Inducers of Human Leukemic Lymphocytes and DAPK-1 Inhibitors
Professor Ignacio Molina and Dr Juan José Díaz-Mochón, Universidad de Granada, Spain
Extracellular Palladium-Catalysed Dealkylation of 5-Fluoro-1-Propargyl-Uracil as a Bioorthogonally Activated Prodrug Approach
Dr Carmen Torres-Sánchez, Loughborough University, United Kingdom
Synthesis of Polystyrene Microspheres and Functionalization with Pd0 Nanoparticles to Perform Bioorthogonal Organometallic Chemistry in Living Cells.
Professor Rosario Sanchez-Martin, GENyO, Pfizer-University of Granada-Junta de Andalucia, Granada, Spain
Assays and Screening
A Yeast Chemical Genetic Screen Identifies New Inhibitors of Human Telomerase
Professor Lea Harrington, GENyO, Institute for Research in Immunology and Cancer of the University of Montreal, Canada
Mechanism of Action Studies
Ret inhibition mechanism-of-action studies in breast cancer
Professor Nancy Hynes, Friedrich Miescher Institute for Biomedical Research (FMI), Basel, Switzerland.
Drug mechanism–of-action studies in Gioblastoma models
Dr Andrew Westhoff, University of Ulm, Germany
High content image-informatics
Professor Anne Carpenter, Broad Institute and MIT, USA
Quantitative imaging in complex in vitro and in vivo models.
Dr Paul Timpson, Garvan Institute, Sydney, Australia
Contributions to Best Practice
Realizing the promise of reverse phase protein arrays for clinical, translational, and basic research
Global RPPA Society
European Cell based Assay Interest Group: Advancing Cell Based Assay Sciences.
The National Phenotypic Screening Centre, University of Dundee, United Kingdom
Read about our industry collaborations